News | Computed Tomography (CT) | February 12, 2020

Smartphone, Laptop Prove Reliable and Accurate for Acute Stroke Decision

A unique assessment of imaging-based recommendations for the administration of IV recombinant tissue plasminogen activator based on unenhanced brain CT scans

Mobile devices proved both reliable and accurate for the clinical decision to administer IV thrombolysis in patients with acute stroke

Appearance of same unenhanced CT scan on three reading systems: E-2620 monitor (Barco) (A), Galaxy S8 Plus (Samsung) smartphone (B) and ThinkPad T460s laptop computer (Lenovo) (C).

February 12, 2020 — Mobile devices proved both reliable and accurate for the clinical decision to administer IV thrombolysis in patients with acute stroke, according to an ahead-of-print article in the April issue of the American Journal of Roentgenology (AJR).

To assess reliability and accuracy of IV thrombolysis recommendations made after interpretation of head computed tomography (CT) images of patients with acute stroke symptoms displayed on smartphone or laptop reading systems—compared with those made after interpretation of images displayed on a medical workstation monitor—Antonio J. Salazar at the University of Los Andes in Bogotá, Columbia utilized a factorial design with 188 patients, four radiologists, and three reading systems to produce 2,256 interpretations.

To evaluate reliability, Salazar and colleagues calculated the intraobserver and interobserver agreements using the intraclass correlation coefficient (ICC) and five interpretation variables: hemorrhagic lesions, intraaxial neoplasm, stroke dating (acute, subacute, chronic), hyperdense arteries, and infarct size assessment. Accuracy equivalence tests were also performed for the IV thrombolysis recommendation; for this variable, sensitivity, specificity, and ROC curves were evaluated.

Good or very good intraobserver agreements were observed for all the variables. Specifically, for those variables required to establish contraindications for IV thrombolysis, the agreements were ranked as very good. “This finding is important,” wrote Salazar et al., “because it reflects the good performance of mobile devices to evaluate the most significant imaging variables for clinical decisions.”

For IV thrombolysis recommendation, the main subject of this evaluation, the interobserver agreements for the three reading systems were ranked as very good (ICC > 0.88). Similarly, very good intraobserver agreements were observed for all comparisons (ICC > 0.84). The AUC values (0.83–0.84) and sensitivities (0.94–0.95) for IV thrombolysis recommendation were equivalent among all the reading systems at a 5 percent equivalent threshold.

A unique assessment of imaging-based recommendations for the administration of IV recombinant tissue plasminogen activator based on unenhanced brain CT scans, Salazar also noted: “These results constitute a strong foundation for the development of mobile-based telestroke services because they increase neuroradiologist availability and the possibility of using reperfusion therapies in resource-limited countries.”

For more information: www.arrs.org

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 U.S. Surgeon General Jerome Adams, M.D., M.Ph demonstrates how the general public can make their own face masks for non-clinical use.

U.S. Surgeon General Jerome Adams, M.D., M.Ph. demonstrates how the general public can make their own face masks for non-clinical use.

News | Coronavirus (COVID-19) | April 04, 2020 | By Melinda Taschetta-Millane
April 4, 2020 — The Centers for Disease Control and Prevention (CDC)
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
Recommended best practices for nuclear imaging departments under the COVIF-19 pandemic have been issues by the ASNC and SNMMI. #COVID19 #ASNC #SNMMI #Coronavirus #SARScov2
News | Coronavirus (COVID-19) | April 03, 2020
April 3, 2020 — A new guidance document on best practices to maintain safety and minimize contamination in nuclear im
Jeannie Danker, M.D. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Jeannie Danker, M.D. Photo courtesy of The Ohio State University Wexner Medical Center

News | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane
April 3, 2020 — The radiology world has lost a dedicated leader due to...
An estimated 44 million people worldwide are currently living with Alzheimer’s disease, the most common form of dementia. About 5.8 million people in the United States live with the disease, where it is the sixth leading cause of death overall. While there is not yet a cure for Alzheimer’s, researchers are working to find treatment options to delay its onset and prevent it from developing.

Image courtesy of Insightec

Feature | Ultrasound Imaging | April 02, 2020 | By Katie Caron
An estimated 44 million people worldwide are currently living with...
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Getty Images

Feature | Coronavirus (COVID-19) | April 02, 2020 | Jilan Liu and HIMSS Greater China Team
Information technologies have played a pivotal role in China’s response to the novel coronavirus...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

News | Ultrasound Imaging | April 02, 2020
April 2, 2020 — Esaote, an Italian company among the world leader
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Updated CT scoring criteria from AJR considers both lobe involvement and changes in CT findings to quantitatively and accurately evaluate the progression of COVID-19 pneumonia

CT scoring criteria were applied to images from sequential chest CT examinations. A, Initial chest CT image obtained 2 days after onset of symptoms shows small region of subpleural ground-glass opacities in right lower lobe, for CT score of 1. B, Chest CT image obtained on day 3 of treatment shows slightly enlarged region of subpleural ground-glass opacities with partial crazy-paving pattern and consolidation, for CT score of 3. C, Chest CT image obtained on day 5 of treatment shows partial resolution of consolidation, for CT score of 2. D, Chest CT image obtained on day 14 of treatment shows continued resolution of consolidation with minimal residual ground-glass opacities, for CT score of 1. Image courtesy of American Journal of Roentgenology (AJR)

News | Computed Tomography (CT) | April 02, 2020
April 2, 2020 — Updated computed t...